Santa Barbara sued over water rate increases
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Businesses have to pay to promote downtown
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: A look at the exciting year ahead for the Business Times
The masthead signals that we’re at issue 52 and about to start into a new year. So I’ll exercise my editor’s privilege and provide an update from the Business Times newsroom as we launch Volume 18. On April 13, CSU Channel Islands President Erika Beck will be the keynote speaker and special honoree at this Read More →
Our view: SLO to Denver flight great for economy
Reports that San Luis Obispo County Regional Airport has landed a coveted daily nonstop flight to Denver came seemingly out of the blue. But, in fact, the announcement was the result of nearly a decade of effort by business and community leaders to give SLO County travelers an option that provides a same day connection Read More →
Letter to the editor: Stop asking Trump to release tax returns
Dear Editor: When I read your commentary, “Time for Trump to release tax returns, explain Russian ties” (Feb. 17 issue), I couldn’t believe my eyes. The editor of a business-oriented periodical spouting left-wing conspiracy theories and repeating fake news. Let me start by sharing my opinion that President Trump is a friend of the workingman Read More →
Fienup: At last, an end to the ‘New Normal’
By Matthew Fienup There is one clear lesson from the first 30 days of the Trump economy. The so-called “New Normal,” a belief in the inevitability of poor economic performance following the Great Recession, is now dead. I wish I could also say that a return to robust economic growth is just around the corner Read More →
Study shows Amgen’s Blincyto a better alternative than chemotherapy
Amgen’s new leukemia drug Blincyto increases the length of survival among high-risk patients, according to a study released by the New England Journal of Medicine. Results from its Phase 3 Tower study revealed that Blincyto almost doubled median overall survival versus chemotherapy among adult patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic Read More →
